02:10 PM EDT, 08/11/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

We keep our price target at $1.90, 6.3x our '25 sales-per-share view ($0.30), above BLDP's 3-year average (~5x) on regulatory tailwinds. We lower our '25 sales view by $4M to $90M (LPS to -$0.30 from -$0.29) and cut '26's by $11M to $116M (LPS to -$0.21 from -$0.26). BLDP's backlog fell in Q2 (to $146M) but still provides some support, with its 12-month sales backlog of $84M requiring an additional $18M of sales to hit our N12M sales view ($102M), which we think is reasonable as OBBBA-related uncertainty fades. We still believe significant hydrogen market activity remains far off, but expense reductions continue to be important, and we are encouraged by BLDP's target of positive cash flow by YE 27 and its announcement of a new restructuring program that should cut opex by an additional 30% beyond the 30% reductions targeted by its existing restructuring program. The OBBBA provides regulatory tailwinds, extending Section 45-V (the hydrogen PTC) through YE 27 and Section 48-E (the fuel cell ITC) through YE 35.